APA aipamena

Hagen, P., D’Souza, A., Hari, P., Davila, O., Zhang, M., Vesole, D. H., . . . Stiff, P. J. (2020). Busulfan, Melphalan, and Bortezomib Compared to Melphalan as a High Dose Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow Up of a Novel High Dose Regimen. Leuk Lymphoma.

Chicago Style aipamena

Hagen, Patrick, Anita D’Souza, Parameswaran Hari, Omar Davila, Mei-Jie Zhang, David H. Vesole, Scott E. Smith, Tulio E. Rodriguez, and Patrick J. Stiff. "Busulfan, Melphalan, and Bortezomib Compared to Melphalan As a High Dose Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow Up of a Novel High Dose Regimen." Leuk Lymphoma 2020.

MLA aipamena

Hagen, Patrick, et al. "Busulfan, Melphalan, and Bortezomib Compared to Melphalan As a High Dose Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow Up of a Novel High Dose Regimen." Leuk Lymphoma 2020.